Carprodyl Quadri 120mg - per Tablet

Description

Carprodryl Quadri may only be supplied with a valid veterinary prescription issued by your vet. You should only purchase Carprodryl Quadri if you have or are in the process of arranging such a prescription. See information bar for further details.

Carprodyl Quadri tablets are scored circular beige tablets containing as active ingredient 120mg carprofen.

Carprodyl Quadri tablets are used for analgesia and reduction of inflammation caused by musculo-skeletal disorders and degenerative joint disease of the dog. Carprodyl Quadri tablets can also be used in the management of post-operative pain in dogs.

For oral administration. The tablets are flavoured and are readily consumed by most dogs when offered. An initial dose of 4 mg carprofen/kg bodyweight/day is recommended to be given as a single dose or in two equally divided doses. Subject to clinical response the dose may be reduced. To extend analgesic and anti-inflammatory cover post operatively parenteral therapy with carprofen injection may be followed with carprofen tablets at 4mg/kg/day for up to 5 days.   Duration of treatment will be dependent upon the response seen. Long-term treatment should be under regular veterinary supervision. Do not exceed stated dose.

Contra-indications warnings etc
The elimination time of NSAIDs including Carprodyl in the cat is longer than in the dog and the therapeutic index is narrower. Consequently do not use in cats. Do not use in pregnant or lactating bitches. Do not use in cases of known hypersensitivity to the active substance or to any of the excipients. Do not use in dogs suffering from cardiac hepatic or renal disease where there is a possibility of gastro-intestinal ulceration or bleeding or where there is evidence of a blood dyscrasia or hypersensitivity to the product. Do not use in puppies less than 4 months of age.   Special precautions for use in animals Use in aged dogs may involve additional risk. If such a use cannot be avoided dogs may require careful clinical management. Avoid use in any dehydrated hypovolaemic or hypotensive dog as there is a potential risk of increased renal toxicity. Concurrent administration of potentially nephrotoxic drugs should be avoided. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection appropriate concurrent antimicrobial therapy should be instigated.   Do not administer other NSAIDs concurrently or within 24 hours. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects. Response to long-term treatment should be monitored at regular intervals by a veterinary surgeon. Special precautions to be taken by the person administering the veterinary medicinal product to animals In the event of accidental ingestion of the tablets seek medical advice and show the doctor the package leaflet. Wash hands after handling the product.

Legal Category
Carprodyl Quadri is a POM-V (Pet Prescription Required)